Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

50.9K
Overview
50.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sleep disturbances in patients with vasculitis.

Sleep medicine·2026
Same author

From Global Insights to Local Action: Bridging Vaccine Design and Manufacturing Gaps in H5N1 Pandemic Readiness.

Vaccines·2026
Same author

Multiplex gene editing suppresses random integration of hepatitis B virus DNA in chronically infected liver.

Molecular therapy. Nucleic acids·2026
Same author

Trends in funding for coronavirus vaccine research and development: implications for preparedness against future coronavirus threats.

NPJ vaccines·2026
Same author

Unpacking the mRNA Supply Chain: Challenges and Opportunities for Global Health.

Vaccines·2026
Same author

Clinical Characteristics and Severity of Rhinovirus/Enterovirus-Associated Hospitalizations: A Multicountry Analysis From the Global Influenza Hospital Surveillance Network, 2017-2024.

Open forum infectious diseases·2026
Same journal

Combination adjuvants: clinical value and mechanisms of action.

Current opinion in virology·2026
Same journal

Editorial Overview: Immunopathogenesis in viral disease.

Current opinion in virology·2026
Same journal

Architecture and evolution of viral complement evasion.

Current opinion in virology·2026
Same journal

The HEV capsid through a dynamic lens: parallels and divergence from caliciviruses.

Current opinion in virology·2026
Same journal

When structural rationales fall short: revisiting the immunogenicity of herpesvirus prefusion and postfusion glycoprotein B.

Current opinion in virology·2026
Same journal

Beyond brain fog: viral proteins as convergent drivers of neuroinflammation and proteinopathy.

Current opinion in virology·2026
See all related articles

Related Experiment Video

Updated: Dec 24, 2025

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

37.5K

Tracking progress in universal influenza vaccine development.

Julie Ostrowsky1, Meredith Arpey1, Kristine Moore1

  • 1Center for Infectious Disease Research and Policy, University of Minnesota, 420 Delaware St SE, Minneapolis, MN 55455, USA.

Current Opinion in Virology
|April 13, 2020
PubMed
Summary
This summary is machine-generated.

New universal influenza vaccines aim for broader, longer-lasting protection by targeting conserved antigens and T cell responses, overcoming limitations of current vaccines against seasonal and pandemic strains.

More Related Videos

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

13.0K
A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

25.9K

Related Experiment Videos

Last Updated: Dec 24, 2025

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

37.5K
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

13.0K
A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

25.9K

Area of Science:

  • Vaccinology
  • Immunology
  • Infectious Disease

Background:

  • Conventional influenza vaccines target variable hemagglutinin antigens, offering limited protection against evolving seasonal and novel pandemic strains.
  • Suboptimal protection and lack of cross-strain immunity are key limitations of current influenza vaccine technologies.

Purpose of the Study:

  • To review and track the development of universal influenza vaccine technologies.
  • To provide stakeholders with a centralized information source on universal influenza vaccine research progress.

Main Methods:

  • Review of current research and development in universal influenza vaccine technologies.
  • Analysis of strategies targeting conserved antigens and T cell responses.

Main Results:

  • Emerging technologies focus on conserved antigens and T cell immunity for broader protection.
  • A new 'Universal Influenza Vaccine Technology Landscape' is being developed to track progress.

Conclusions:

  • Universal influenza vaccines represent a significant advancement over conventional vaccines.
  • Improved tracking and collaboration are crucial for accelerating the development and implementation of universal influenza vaccines.